The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Anti-Inflammatory Drugs as Anticancer Agents
Open accessAbstract
Inflammation is strictly associated with cancer and plays a key role in tumor development and progression. Several epidemiological studies have demonstrated that inflammation can predispose to tumors, therefore targeting inflammation and the molecules involved in the inflammatory process could represent a good strategy for cancer prevention and therapy. In the past, several clinical studies have demonstrated that many anti-inflammatory agents, including non-steroidal anti-inflammatory drugs (NSAIDs), are able to interfere with the tumor microenvironment by reducing cell migration and increasing apoptosis and chemo-sensitivity. This review focuses on the link between inflammation and cancer by describing the anti-inflammatory agents used in cancer therapy, and their mechanisms of action, emphasizing the use of novel anti-inflammatory agents with significant anticancer activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Complexity of coupled human and natural systems
Liu, J., Dietz, T., Carpenter, S. R., Alberti, M., Folke, C., Moran, E., Pell, A. N., Deadman, P., Kratz, T., Lubchenco, J., et al. (2007) · Science · doi:10.1126/science.1144004 · Cited by 3,624
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
The PI3K Pathway in Human Disease
Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017) · Cell · doi:10.1016/j.cell.2017.07.029 · Cited by 2,749
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Mitogen-activated protein kinases in innate immunity
Arthur, J. S. C., & Ley, S. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3495 · Cited by 1,855
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Thun, M. J., Namboodiri, M. M., & Heath, C. W. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252301 · Cited by 1,673
MAP Kinases in the Immune Response
Dong, C., Davis, R. J., & Flavell, R. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091301.131133 · Cited by 1,662
Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.
Iyer, S. S., & Cheng, G. (2012) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v32.i1.30 · Cited by 1,611
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation
Viatour, P., Merville, M.-P., Bours, V., & Chariot, A. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.009 · Cited by 1,496
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510289 · Cited by 1,441
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044
CREB Is a Regulatory Target for the Protein Kinase Akt/PKB
Du, K., & Montminy, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32377 · Cited by 952
The role of IL-6 and STAT3 in inflammation and cancer
Hodge, D. R., Hurt, E. M., & Farrar, W. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.016 · Cited by 950
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Rajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression
Nieman, M. T., Prudoff, R. S., Johnson, K. R., & Wheelock, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.3.631 · Cited by 789
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
Owens, D. M., & Keyse, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210412 · Cited by 777
ERK implication in cell cycle regulation
Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 750
Gao, S. P., Mark, K. G., Leslie, K., Pao, W., Motoi, N., Gerald, W. L., Travis, W. D., Bornmann, W., Veach, D., Clarkson, B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31871 · Cited by 666
Kune, G. A., Kune, S., & Watson, L. F. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym193 · Cited by 654
Inflammation as a Tumor Promoter in Cancer Induction
Philip, M., Rowley, D. A., & Schreiber, H. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.006 · Cited by 640
Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis
Riabov, V., Gudima, A., Wang, N., Mickley, A., Orekhov, A., & Kzhyshkowska, J. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00075 · Cited by 628
Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
Ma, B., & Hottiger, M. O. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00378 · Cited by 563
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.055 · Cited by 548
Corley, D. A., Kerlikowske, K., Verma, R., & Buffler, P. (2003) · Gastroenterology · doi:10.1053/gast.2003.50008 · Cited by 527
Sulindac for polyposis of the colon
Waddell, W. R., & Loughry, R. W. (1983) · Journal of Surgical Oncology · doi:10.1002/jso.2930240119 · Cited by 513
Seril, D. N. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.353 · Cited by 467 · cited 1×
“For instance, ulcerative colitis and Crohn’s disease [6] can increase the neoplastic risk and this process is, on the other hand, reduced by the use of anti-inflammatory agents for colitis [7].”
BackgroundA melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Johannessen, C. M., Johnson, L. A., Piccioni, F., Townes, A., Frederick, D. T., Donahue, M. K., Narayan, R., Flaherty, K. T., Wargo, J. A., Root, D. E., et al. (2013) · Nature · doi:10.1038/nature12688 · Cited by 452
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Zhang, L., & Shay, J. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw332 · Cited by 449
Cytokines in cancer immunity and immunotherapy
Smyth, M. J., Cretney, E., Kershaw, M. H., & Hayakawa, Y. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00199.x · Cited by 412
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G. L., Loar, A., Rodabough, R. J., White, E., & McTiernan, A. (2003) · PubMed · Cited by 411
Sulindac for polyposis of the colon
Waddell, W. R., Ganser, G. F., Cerise, E. J., & Loughry, R. W. (1989) · The American Journal of Surgery · doi:10.1016/0002-9610(89)90442-x · Cited by 409
Yang, Y., Kim, S. C., Yu, T., Yi, Y.-S., Rhee, M. H., Sung, G.-H., Yoo, B. C., & Cho, J. Y. (2014) · Mediators of Inflammation · doi:10.1155/2014/352371 · Cited by 406
Anti-Inflammatory Responses of Resveratrol
Das, S., & Das, D. (2007) · Inflammation & Allergy-Drug Targets · doi:10.2174/187152807781696464 · Cited by 382
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Anti-Inflammatory Agents for Cancer Therapy
Rayburn, E. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.05 · Cited by 341
Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
Kawanishi, S., Ohnishi, S., Ma, N., Hiraku, Y., & Murata, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081808 · Cited by 288
Role of infiltrated leucocytes in tumour growth and spread
Lin, E. Y., & Pollard, J. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601705 · Cited by 278
Therapeutic options for 5-lipoxygenase inhibitors
Werz, O., & Steinhilber, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.009 · Cited by 260
Arachidonic Acid Stimulates Prostate Cancer Cell Growth: Critical Role of 5-Lipoxygenase
Ghosh, J., & Myers, C. E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6799 · Cited by 259
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Akinleye, A., Avvaru, P., Furqan, M., Song, Y., & Liu, D. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-88 · Cited by 254
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martínez, A., & Mulshine, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118480 · Cited by 249
Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study
Cruz–Correa, M., Hylind, L. M., Romans, K. E., Booker, S. V., & Giardiello, F. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.31890 · Cited by 245
The role of COX-2 inhibition in breast cancer treatment and prevention
Arun, B., & Goss, P. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.042 · Cited by 235
The Mitogen-Activated Protein Kinase (MAPK) Pathway: Role in Immune Evasion by Trypanosomatids
Soares-Silva, M., Diniz, F. F., Gomes, G. N., & Bahia, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00183 · Cited by 232
Canna, K., McArdle, P. A., McMillan, D. C., McNicol, A.-M., Smith, G. W., McKee, R. F., & McArdle, C. S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602419 · Cited by 226
Inflammation, Cancer, and Targets of Ginseng
Hofseth, L. J., & Wargovich, M. J. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.1.183s · Cited by 207
Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis
Tomohiro, N., Yasuko, K., & Sei-Itsu, M. (1983) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(83)90106-6 · Cited by 198
Stark, L. A., Din, F. V. N., Zwacka, R. M., & Dunlop, M. G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0529fje · Cited by 191
Candelario-Jalil, E., Taheri, S., Yang, Y., Sood, R., Grossetete, M., Estrada, E. Y., Fiebich, B. L., & Rosenberg, G. A. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127035 · Cited by 189
5-Lipoxygenase: Cellular Biology and Molecular Pharmacology
Werz, O. (2002) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010023344959 · Cited by 188
Ebrahimi, S., Hosseini, M., Shahidsales, S., Maftouh, M., Ferns, G. A., Ghayour-Mobarhan, M., Hassanian, S. M., & Avan, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170206142658 · Cited by 183
Adverse drug interactions involving common prescription and over-the-counter analgesic agents
Hersh, E. V., Pinto, A., & Moore, P. A. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.12.003 · Cited by 182
Antitumor, Anti-Inflammatory and Analgesic Property of Embelin, a Plant Product
Chitra, M., Sukumar, E., Suja, V., & Devi, S. (1994) · Chemotherapy · doi:10.1159/000239181 · Cited by 175
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
de Groot, D. J. A., de Vries, E. G. E., Groen, H. J. M., & de Jong, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.001 · Cited by 175
Parasite Infection, Carcinogenesis and Human Malignancy
van Tong, H., Brindley, P. J., Meyer, C. G., & Velavan, T. P. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.034 · Cited by 173
Gridelli, C., Gallo, C., Ceribelli, A., Gebbia, V., Gamucci, T., Ciardiello, F., Carozza, F., Favaretto, A. G., Daniele, B., Galetta, D., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70146-8 · Cited by 169
Sassano, A., & Platanias, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.036 · Cited by 168
Knight, T., & Irving, J. A. E. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00160 · Cited by 164
The mechanisms of lipoxygenase inhibitor-induced apoptosis in human breast cancer cells
Tong, W., Ding, X., & Adrian, T. E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02014-4 · Cited by 164
Bromwich, E. J., McArdle, P. A., Canna, K., McMillan, D. C., McNicol, A.-M., Brown, M., & Aitchison, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601400 · Cited by 162
Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer
Baron, J. A. (2003) · Progress in Experimental Tumor Research · doi:10.1159/000071364 · Cited by 161
Prostaglandin E synthases: Understanding their pathophysiological roles through mouse genetic models
Hara, S., Kamei, D., Sasaki, Y., Tanemoto, A., Nakatani, Y., & Murakami, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.007 · Cited by 161
Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., & Verma, I. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8070-8083.2003 · Cited by 161
Steven, A., & Seliger, B. (2016) · Oncotarget · doi:10.18632/oncotarget.7721 · Cited by 161
Involvement of Chemokine Receptors in Organ-Specific Metastasis
Zlotnik, A. (2006) · Contributions to Microbiology · doi:10.1159/000092973 · Cited by 159
Jana, N. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7511-x · Cited by 159
Lipoxygenase Inhibitors Abolish Proliferation of Human Pancreatic Cancer Cells
Ding, X., Iversen, P. L., Cluck, M. W., Knezetic, J. A., & Adrian, T. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1012 · Cited by 155
Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer Cells
Yano, A., Fujii, Y., Iwai, A., Kageyama, Y., & Kihara, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2085 · Cited by 148
Aspirin Induces Apoptosis through the Inhibition of Proteasome Function
Dikshit, P., Chatterjee, M., Goswami, A., Mishra, A., & Jana, N. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602629200 · Cited by 145
Chemokines: Not just leukocyte chemoattractants in the promotion of cancer
Strieter, R. M. (2001) · Nature Immunology · doi:10.1038/86286 · Cited by 140
Kashfi, K., Rayyan, Y. M., QIAO, L., Williams, J. L., Chen, J., Soldato, P. D., Traganos, F., & Rigas, B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042754 · Cited by 134
Nuclear Factor-Kappa B: From Clone to Clinic
Ahn, K., Sethi, G., & Aggarwal, B. B. (2007) · Current Molecular Medicine · doi:10.2174/156652407782564363 · Cited by 134
Nitric Oxide, a Mediator of Inflammation, Suppresses Tumorigenesis
Hussain, S. P., Trivers, G. E., Hofseth, L. J., He, P., Shaikh, I. A., Mechanic, L. E., Doja, S., Jiang, W., Subleski, J. J., Shorts, L., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2201 · Cited by 131
Wang, H., Li, M., Rinehart, J. J., & Zhang, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0829-3 · Cited by 130
Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer
Xu, J., Yao, Y., Zhang, H., Szmitkowski, M., Mäkinen, M. J., Li, P., Xia, D., Yang, J. J., Wu, Y., & Wu, H. (2016) · Medicine · doi:10.1097/md.0000000000002502 · Cited by 130
Qiu, X., Ma, J., Wang, K., & Zhang, H. (2016) · Oncotarget · doi:10.18632/oncotarget.13715 · Cited by 125
Therapy Insight: potential of statins for cancer chemoprevention and therapy
Katz, M. S. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0097 · Cited by 123
Guo, Y., Nie, Q. H., MacLean, A. L., Li, Y., Lei, J., & Li, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1662 · Cited by 123
CREB is a critical regulator of normal hematopoiesis and leukemogenesis
Cheng, J. C., Kinjo, K., Judelson, D. R., Chang, J. C.-C., Wu, W. S., Schmid, I., Shankar, D. B., Kasahara, N., Stripecke, R., Bhatia, R., et al. (2007) · Blood · doi:10.1182/blood-2007-04-083600 · Cited by 121
The phosphoinositide 3-kinase pathway and therapy resistance in cancer
Brown, K., & Toker, A. (2015) · F1000Prime Reports · doi:10.12703/p7-13 · Cited by 121
Hoque, A. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi026 · Cited by 119
Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer
Gu, Q., Wang, J. D., Xia, H. H., Lin, M. C.-M., He, H., Zou, B., Tu, S. P., Yang, Y., Liu, X., Lam, S. K., et al. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh345 · Cited by 115
12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells
Wong, B. C. Y., Wang, W. P., Cho, C. H., Fan, X. M., Lin, M. C., Kung, H. F., & Lam, S. K. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1349 · Cited by 114
Dandekar, D. S., Lopez, M. H., Carey, R. I., & Lokeshwar, B. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.20878 · Cited by 105
Aberrant regulation of Wnt signaling in hepatocellular carcinoma
Liu, L., Xie, S., Chen, Y.-T., Xue, J.-L., Zhang, C., & Zhu, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i33.7486 · Cited by 102
Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy
Hassan, H. T. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.10.008 · Cited by 101
Tan, X., Wang, S., Yang, B., Zhu, L., Yin, B., Chao, T., Zhao, J., Yuan, J., Qiang, B., & Peng, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049570 · Cited by 100
Pruthi, R. S., Derksen, J. E., Moore, D. T., Carson, C. C., Grigson, G., Watkins, C., & Wallen, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2067 · Cited by 97
Lung Cancer Chemoprevention with Celecoxib in Former Smokers
Mao, J. T., Roth, M. D., Fishbein, M. C., Aberle, D. R., Zhang, Z., Rao, J. Y., Tashkin, D. P., Goodglick, L., Holmes, E. C., Cameron, R. B., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0078 · Cited by 96
NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis
Zhao, X., Xu, Z., & Li, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-01644-0 · Cited by 96
Greenspan, E. J., Madigan, J. P., Boardman, L. A., & Rosenberg, D. W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0021 · Cited by 95
Schönthal, A. H., Chen, T. C., Hofman, F. M., Louie, S. G., & Petasis, N. A. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.197 · Cited by 95
Anti-Inflammatory Agents as Cancer Therapeutics
Kashfi, K. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57002-5 · Cited by 94
Nakata, E., Mason, K. A., Hunter, N. R., Husain, A., Raju, U., Liao, Z. X., Ang, K. K., & Milas, L. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.09.061 · Cited by 94
Schaible, A. M., Traber, H., Temml, V., Noha, S. M., Filosa, R., Peduto, A., Weinigel, C., Barz, D., Schuster, D., & Werz, O. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.015 · Cited by 92
Self-citationHeo, J. Y., Kim, H. J., Kim, S., Park, K., Park, S., Kim, S. W., Nam, D., Jang, H.-J., Lee, S., Ahn, K. S., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.04.015 · Cited by 92
Combination regimen with statins and NSAIDs: A promising strategy for cancer chemoprevention
Xiao, H., & Yang, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23718 · Cited by 92
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours
Scotton, C. J., Milliken, D., Wilson, J. L., Raju, S., & Balkwill, F. R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2020 · Cited by 91
Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway
Petrenko, O., & Moll, U. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.052 · Cited by 90
Wang, H., Wang, Y., Rayburn, E. R., Hill, D. L., Rinehart, J. J., & Zhang, R. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.4.947 · Cited by 88
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Salojin, K. V., & Oravecz, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006639 · Cited by 88
Bardia, A., Ebbert, J. O., Vierkant, R. A., Limburg, P. J., Anderson, K., Wang, A. H., Olson, J. E., Vachon, C., & Cerhan, J. R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk200 · Cited by 86
Chen, X., Li, N., Wang, S., Wu, N., Hong, J., Jiao, X., Krasna, M. J., Beer, D. G., & Yang, C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.14.1053 · Cited by 84
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family
Jean, D., & Bar‐Eli, M. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4351-0_3 · Cited by 80
Murray, M. Y., Rushworth, S. A., Zaitseva, L., Bowles, K. M., & MacEwan, D. J. (2013) · Cell Cycle · doi:10.4161/cc.25251 · Cited by 80
Boado, R. J., Pardridge, W. M., Vinters, H. V., & Black, K. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9044 · Cited by 78
Dai, Y., Qiao, L., Chan, K. W., Yang, M., Ye, J., Ma, J., Zou, B., Gu, Q., Wang, J., Pang, R. W. C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4754 · Cited by 77
Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family
Jean, D., & Bar‐Eli, M. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007128101751 · Cited by 77
Dexamethasone reduces the interstitial fluid pressure in a human colon adenocarcinoma xenograft.
Kristjansen, P. E. G., Boucher, Y., & Jain, R. K. (1993) · PubMed · Cited by 76
van Wijngaarden, J., van Beek, E. R., van Rossum, G., van der Bent, C., Hoekman, K., van der Pluijm, G., van der Pol, M. A., Broxterman, H. J., van Hinsbergh, V. W. M., & Löwik, C. W. G. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.010 · Cited by 75
Dittmann, K., Mayer, C., Ohneseit, P., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.065 · Cited by 75
Wnt signaling dynamics in head and neck squamous cell cancer tumor‐stroma interactions
Le, P. N., Keysar, S. B., Miller, B., Eagles, J. R., Chimed, T.-S., Reisinger, J., Gomez, K. E., Nieto, C., Jackson, B. C., Somerset, H., et al. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22937 · Cited by 74
Knab, L. M., Grippo, P. J., & Bentrem, D. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i31.10729 · Cited by 70
Celecoxib and Curcumin Additively Inhibit the Growth of Colorectal Cancer in a Rat Model
Shpitz, B., Giladi, N., Sagiv, E., et al. (2006) · Digestion · doi:10.1159/000098655 · Cited by 70
Ponthan, F., Wickström, M., Gleissman, H., Fuskevåg, O., Segerström, L., Sveinbjørnsson, B., Redfern, C. P. F., Eksborg, S., Kogner, P., & Johnsen, J. I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1908 · Cited by 67
Kojima, F., Kapoor, M., Yang, L., Fleishaker, E. L., Ward, M. R., Monrad, S. U., Kottangada, P. C., Pace, C. Q., Clark, J. A., Woodward, J. G., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.8361 · Cited by 64
NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action
Rigas, B., & Williams, J. L. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.022 · Cited by 64
Targeting CREB Pathway Suppresses Small Cell Lung Cancer
Xia, Y., Zhan, C., Feng, M., Leblanc, M., Ke, E., Yeddula, N., & Verma, I. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0576 · Cited by 63
Colorectal cancer prevention: Is an ounce of prevention worth a pound of cure?
Gill, S., & Sinicrope, F. A. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.038 · Cited by 61
Herrera, F. G., Chan, P., Doll, C., Milosevic, M., Oza, A. M., Syed, A., Pintilie, M., Levin, W., Manchul, L., & Fyles, A. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.08.024 · Cited by 60
Cyclooxygenase Inhibitors Down Regulate P-glycoprotein in Human Colorectal Caco-2 Cell Line
Zrieki, A., Farinotti, R., & Buyse, M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9596-1 · Cited by 55
Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial
Zhang, S. M., Cook, N. R., Manson, J. E., Lee, I.-M. M., & Buring, J. E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604240 · Cited by 55
Yin, T., Wang, G., Ye, T., & Wang, Y. (2016) · Scientific Reports · doi:10.1038/srep19534 · Cited by 55
Sabichi, A. L., Lee, J. J., Grossman, H. B., Liu, S., Richmond, E. S., Czerniak, B. A., de la Cerda, J., Eagle, C. J., Viner, J. L., Palmer, J. L., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0036 · Cited by 50
Karthaus, M., Balló, H., Abenhardt, W., Steinmetz, T., Geer, T., Schimke, J., Braumann, D., Behrens, R., Behringer, D. M., Kindler, M., et al. (2005) · Oncology · doi:10.1159/000086971 · Cited by 49
Karjalainen, M. J., Neuvonen, P. J., & Backman, J. T. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00252.x · Cited by 47
The Role of Cytokines and Chemokines on Tumor Progression: A Review
Ardestani, S. K., Inserra, P. F., Solkoff, D., & WATSON, R. R. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.99021.x · Cited by 47
Saini, M. K., & Sanyal, S. N. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.03.007 · Cited by 46
Siegelin, M. D., Gaiser, T., Habel, A., & Siegelin, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.031 · Cited by 44
Javle, M. M., Cao, S., Durrani, F. A., Pendyala, L., Lawrence, D. D., Smith, P. F., Creaven, P. J., Noel, D., Iyer, R. V., & Rustum, Y. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0551 · Cited by 43
Wang, H., Li, M., Rinehart, J. J., & Zhang, R. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0759-9 · Cited by 42
CREB: A Key Regulator of Normal and Neoplastic Hematopoiesis
Sandoval, S., Pigazzi, M., & Sakamoto, K. M. (2009) · Advances in Hematology · doi:10.1155/2009/634292 · Cited by 39
Tumor Angiogenesis, Macrophages, and Cytokines
Bando, H., & Toi, M. (2000) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4221-6_21 · Cited by 38
Fabi, A., Metro, G., Papaldo, P., Mottolese, M., Melucci, E., Carlini, P., Sperduti, I., Russillo, M., Gelibter, A. J., Ferretti, G., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0650-1 · Cited by 38
Ghosh, J., & Myers, C. E. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4793-8_84 · Cited by 36
Howard, E. W., Lee, D. T., Chiu, Y. T., Chua, C. W., Wang, X., & Wong, Y. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23355 · Cited by 36
Tong, W., Ding, X., Talamonti, M., Bell, R. H., & Adrian, T. E. (2007) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000231477.22901.8a · Cited by 34
Phương, N. T. T., Lim, S., Kim, Y. M., & Kang, K. W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.003 · Cited by 31
Sulindac activates NF-κB signaling in colon cancer cells
Mladenova, D. N., Pangon, L., Currey, N., Ng, I., Musgrove, E. A., Grey, S. T., & Kohonen‐Corish, M. R. J. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-73 · Cited by 31
Gradilone, A., Pulcinelli, F. M., Lotti, L. V., Trifirò, E., Martino, S., Gandini, O., Gianni, W., Frati, L., Aglianò, A. M., & Gazzaniga, P. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133178 · Cited by 29
Zhao, H., Liu, J., Song, L., Liu, Z., Han, G., Yuan, D., Wang, T., Dun, Y., Zhou, Z., Liu, Z., et al. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12668 · Cited by 29
Castro‐Caldas, M., Mendes, A. F., Duarte, C. B., & Lopes, M. C. (2003) · Mediators of Inflammation · doi:10.1080/09629350310001633351 · Cited by 25
Akt Kinase-Interacting Protein 1 Signals through CREB to Drive Diffuse Malignant Mesothelioma
Yamada, T., Amann, J. M., Fukuda, K., Takeuchi, S., Fujita, N., Uehara, H., Iwakiri, S., Itoi, K., Shilo, K., Yano, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0858 · Cited by 20
Influence of 5-Lipoxygenase on in vitro Growth of Human Mammary Carcinoma Cell Line MCF-7
Przylipiak, A., Hafner, J., Przylipiak, J., Köhn, F.-M., Runnebaum, B., & Rabe, T. (1998) · Gynecologic and Obstetric Investigation · doi:10.1159/000010000 · Cited by 17
Saito, H., Yamada, Y., Takaya, S., Osaki, T., & Ikeguchi, M. (2015) · Surgery Today · doi:10.1007/s00595-015-1165-8 · Cited by 16
Cited by
Jalilian, E., Abolhasani-Zadeh, F., Afgar, A., Samoudi, A., Zeinalynezhad, H., & Langroudi, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-48073-w · Cited by 18
Metadata
- Authors
- Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-09
- Volume
- 21
- Issue
- 7
- Pages
- 2605
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3015770209
- Cited by
- 395
- References
- 163
- FWCI
- 25.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.